The Challenges of Detecting Circulating Tumor Cells in Sarcoma
暂无分享,去创建一个
[1] P. Bendahl,et al. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort , 2016, BMC Cancer.
[2] Xiujuan Li,et al. Molecular Imaging for Comparison of Different Growth Factors on Bone Marrow-Derived Mesenchymal Stromal Cells' Survival and Proliferation In Vivo , 2016, BioMed research international.
[3] Klaus Pantel,et al. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. , 2016, Cancer discovery.
[4] Mehmet Toner,et al. Clusters of circulating tumor cells traverse capillary-sized vessels , 2016, Proceedings of the National Academy of Sciences.
[5] Anne-Marie Cleton-Jansen,et al. Osteosarcoma Stem Cells Have Active Wnt/β‐catenin and Overexpress SOX2 and KLF4 , 2016, Journal of cellular physiology.
[6] D. Heymann,et al. Circulating Tumor Cells: A Review of Non-EpCAM-Based Approaches for Cell Enrichment and Isolation. , 2016, Clinical chemistry.
[7] Florian Engert,et al. Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency , 2015, Nature Communications.
[8] J. Sabourin,et al. Circulating tumor cell isolation: the assets of filtration methods with polycarbonate track-etched filters. , 2015, Chinese journal of cancer research = Chung-kuo yen cheng yen chiu.
[9] N. Girard,et al. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas , 2015, Nature Genetics.
[10] C. Nicolazzo,et al. Significance of Circulating Tumor Cells in Soft Tissue Sarcoma , 2015, Analytical cellular pathology.
[11] Z. Cai,et al. Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer , 2015, Tumor Biology.
[12] Yinglong Zhang,et al. Interleukin-11 receptor α is overexpressed in human osteosarcoma, and near-infrared-labeled IL-11Rα imaging agent could detect osteosarcoma in mouse tumor xenografts , 2015, Tumor Biology.
[13] M. Nykter,et al. The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.
[14] M. Cristofanilli,et al. Cancer stem cells: implications for cancer therapy. , 2014, Oncology.
[15] M. Segura,et al. Optimization of rhabdomyosarcoma disseminated disease assessment by flow cytometry , 2014, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[16] Emanuela M. Ghia,et al. Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy , 2014, Proceedings of the National Academy of Sciences.
[17] C. Toulas,et al. Ionizing radiations sustain glioblastoma cell dedifferentiation to a stem-like phenotype through survivin: possible involvement in radioresistance , 2014, Cell Death and Disease.
[18] A. Satelli,et al. Abstract 35: A universal marker for the detection of epithelial-mesenchymal transitioned circulating tumor cells and their prognostic relevance in epithelial cancers , 2014 .
[19] P. Paterlini-Bréchot,et al. Isolation, detection, and immunomorphological characterization of circulating tumor cells (CTCs) from patients with different types of sarcoma using isolation by size of tumor cells: a window on sarcoma-cell invasion , 2014, OncoTargets and therapy.
[20] P. Rutkowski,et al. Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications , 2014, Medical Oncology.
[21] C. Deng,et al. Tumor suppressor p53 cooperates with SIRT6 to regulate gluconeogenesis by promoting FoxO1 nuclear exclusion , 2014, Proceedings of the National Academy of Sciences.
[22] J. Huard,et al. ALDH Activity Correlates with Metastatic Potential in Primary Sarcomas of Bone. , 2014, Journal of cancer therapy.
[23] A. Satelli,et al. Universal marker and detection tool for human sarcoma circulating tumor cells. , 2014, Cancer research.
[24] A. Ridley,et al. Crossing the endothelial barrier during metastasis , 2013, Nature Reviews Cancer.
[25] Sridhar Ramaswamy,et al. Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.
[26] V. Valero,et al. Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer , 2012, Molecular Cancer Therapeutics.
[27] A. Testori,et al. Sarcoma spreads primarily through the vascular system: are there biomarkers associated with vascular spread? , 2012, Clinical & Experimental Metastasis.
[28] A. Żaczek,et al. Epithelial-Mesenchymal Transition: A Hallmark in Metastasis Formation Linking Circulating Tumor Cells and Cancer Stem Cells , 2012, Pathobiology.
[29] V. Valero,et al. Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system , 2012, International journal of cancer.
[30] M. Campone,et al. High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[31] Maximilian Reichert,et al. EMT and Dissemination Precede Pancreatic Tumor Formation , 2012, Cell.
[32] Massimo Cristofanilli,et al. Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment , 2011, Breast Cancer Research.
[33] The risks of radiation exposure related to diagnostic imaging and how to minimise them , 2011, BMJ : British Medical Journal.
[34] Caroline Dive,et al. Circulating tumor cells as a window on metastasis biology in lung cancer. , 2011, The American journal of pathology.
[35] F. Gleeson,et al. The risks of radiation exposure related to diagnostic imaging and how to minimise them , 2011, BMJ : British Medical Journal.
[36] L. Griffith,et al. Growth factor regulation of proliferation and survival of multipotential stromal cells , 2010, Stem Cell Research & Therapy.
[37] G. Mills,et al. Vimentin is a novel AKT1 target mediating motility and invasion , 2010, Oncogene.
[38] K. Matthay,et al. Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow , 2010, Pediatric blood & cancer.
[39] Larry Norton,et al. Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.
[40] J. Brugge,et al. Tumor Self-Seeding: Bidirectional Flow of Tumor Cells , 2009, Cell.
[41] T. Yamashita,et al. Side population cells have the characteristics of cancer stem-like cells/cancer-initiating cells in bone sarcomas , 2009, British Journal of Cancer.
[42] Tanja Fehm,et al. Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients , 2009, Breast Cancer Research.
[43] T. Izumi,et al. Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma. , 2009, Cancer genetics and cytogenetics.
[44] Bethan Psaila,et al. The metastatic niche: adapting the foreign soil , 2009, Nature Reviews Cancer.
[45] Paula D. Bos,et al. Metastasis: from dissemination to organ-specific colonization , 2009, Nature Reviews Cancer.
[46] Yaokai Gan,et al. Increased number of mesenchymal stem cell-like cells in peripheral blood of patients with bone sarcomas. , 2009, Archives of medical research.
[47] G. Vereb,et al. Die hard: Are cancer stem cells the Bruce Willises of tumor biology? , 2009, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[48] K. Matsuoka,et al. Prognostic significance of circulating tumor cells and bone marrow micrometastasis in advanced neuroblastoma. , 2008, Journal of pediatric surgery.
[49] C. Cavaliere,et al. Detection and Characterization of CD133+ Cancer Stem Cells in Human Solid Tumours , 2008, PloS one.
[50] S. Chiou,et al. Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma , 2008, Clinical Cancer Research.
[51] D. Brenner,et al. Cancer risks from diagnostic radiology. , 2008, The British journal of radiology.
[52] D. Brenner,et al. Computed tomography--an increasing source of radiation exposure. , 2007, The New England journal of medicine.
[53] B. Alman,et al. Side population cells isolated from mesenchymal neoplasms have tumor initiating potential. , 2007, Cancer research.
[54] M. Kay,et al. Sarcoma Derived from Cultured Mesenchymal Stem Cells , 2007, Stem cells.
[55] T. Ohta,et al. BRCA1 ubiquitinates RPB8 in response to DNA damage. , 2007, Cancer research.
[56] P. Valk,et al. Positon emission tomography. Basic sciences , 2006 .
[57] Irving L Weissman,et al. Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells. , 2006, Cancer research.
[58] B. Brando,et al. Detecting CD56+/NB84+/CD45- immunophenotype in the bone marrow of patients with metastatic neuroblastoma using flow cytometry. , 2006, Anticancer research.
[59] M. Kalra,et al. Adverse reactions to intravenous iodinated contrast media: an update. , 2006, Current problems in diagnostic radiology.
[60] S. Watson,et al. Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor. , 2006, Cancer research.
[61] J. Roma,et al. Detection of bone marrow micrometastasis and microcirculating disease in rhabdomyosarcoma by a real-time RT-PCR assay , 2006, Journal of Cancer Research and Clinical Oncology.
[62] Edward W Scott,et al. Stem-like cells in bone sarcomas: implications for tumorigenesis. , 2005, Neoplasia.
[63] Christoph Dehio,et al. VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal progenitor cells. , 2005, Biochemical and biophysical research communications.
[64] I. Yaniv,et al. The predictive potential of molecular detection in the nonmetastatic Ewing family of tumors , 2004, Cancer.
[65] P. Meltzer,et al. Mechanisms of sarcoma development , 2003, Nature Reviews Cancer.
[66] L. Trusolino,et al. Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[67] J. Nichols,et al. Functional Expression Cloning of Nanog, a Pluripotency Sustaining Factor in Embryonic Stem Cells , 2003, Cell.
[68] P. Meltzer,et al. Focus on sarcomas. , 2002, Cancer cell.
[69] I. Macdonald,et al. Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.
[70] J. Goldblum,et al. Enzinger and Weiss's Soft Tissue Tumors , 2001 .
[71] H. Hatano,et al. A PCR-ELISA assay for the detection of disseminated osteosarcoma cells in a mouse metastatic model , 2001, Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association.
[72] S. Burchill,et al. Circulating neuroblastoma cells detected by reverse transcriptase polymerase chain reaction for tyrosine hydroxylase mRNA are an independent poor prognostic indicator in stage 4 neuroblastoma in children over 1 year. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[73] A. Chan,et al. Quantitative analysis of circulating tumor cells in peripheral blood of osteosarcoma patients using osteoblast-specific messenger RNA markers: a pilot study. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[74] C. Baird. The pilot study. , 2000, Orthopedic nursing.
[75] O. Delattre,et al. Presence of tumor cells in bone marrow but not in blood is associated with adverse prognosis in patients with Ewing's tumor. Société Française d'Oncologie Pédiatrique. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[76] H. Kovar,et al. Predictive potential of testing for bone marrow involvement in Ewing tumor patients by RT‐PCR: A preliminary evaluation , 1998, International journal of cancer.
[77] J. Sklar,et al. Detection of circulating tumor cells in patients with Ewing's sarcoma and peripheral primitive neuroectodermal tumor. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[78] K. Kelly,et al. Minimal disease detection in patients with alveolar rhabdomyosarcoma using a reverse transcriptase‐polymerase chain reaction method , 1996, Cancer.
[79] G. Thomas,et al. Sensitive detection of occult Ewing's cells by the reverse transcriptase-polymerase chain reaction. , 1995, British Journal of Cancer.
[80] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[81] B. Bryan,et al. Epithelial cell adhesion molecule is expressed in a subset of sarcomas and correlates to the degree of cytological atypia in leiomyosarcomas. , 2015, Molecular and clinical oncology.
[82] A. Satelli,et al. Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response. , 2015, Clinical chemistry.
[83] J. Neradil,et al. Detection of cancer stem cell markers in sarcomas. , 2012, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.
[84] M. Ratajczak. Cancer stem cells--normal stem cells "Jedi" that went over to the "dark side". , 2005, Folia histochemica et cytobiologica.
[85] S. Aaronson,et al. Implications for Cancer Therapy , 2003 .
[86] O. Delattre,et al. Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[87] B. Kågedal,et al. Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrow. , 2003, Clinical chemistry.
[88] K. Ohnuma,et al. A new sensitive and specific combination of CD81/CD56/CD45 monoclonal antibodies for detecting circulating neuroblastoma cells in peripheral blood using flow cytometry. , 2000, Journal of pediatric hematology/oncology.
[89] Robert M. Nishikawa,et al. Preliminary evaluation of an , 1993 .
[90] K. Johnson. An Update. , 1984, Journal of food protection.